Kura Oncology shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Kura Oncology
Tip: Access up to 7 years of quarterly data
All positions including Kura Oncology held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Kura Oncology by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.3M | 712k | 8.85 |
| 2025-06-30 | $4.0M | 699k | 5.77 |
| 2025-03-31 | $4.1M | 623k | 6.60 |
| 2024-12-31 | $5.5M | 636k | 8.71 |
| 2024-09-30 | $12M | 625k | 19.54 |
| 2024-06-30 | $13M | 611k | 20.59 |
| 2024-03-31 | $13M | 599k | 21.33 |
| 2023-12-31 | $8.3M | 580k | 14.38 |
| 2023-09-30 | $5.1M | 563k | 9.12 |
| 2023-06-30 | $5.0M | 477k | 10.58 |
| 2023-03-31 | $5.8M | 471k | 12.23 |
| 2022-12-31 | $5.8M | 469k | 12.41 |
| 2022-09-30 | $6.2M | 451k | 13.66 |
| 2022-06-30 | $8.6M | 470k | 18.33 |
| 2022-03-31 | $7.7M | 478k | 16.08 |
| 2021-12-31 | $6.5M | 466k | 14.00 |
| 2021-09-30 | $8.5M | 455k | 18.73 |
| 2021-06-30 | $9.4M | 451k | 20.85 |
| 2021-03-31 | $13M | 443k | 28.27 |
| 2020-12-31 | $14M | 422k | 32.66 |
| 2020-09-30 | $11M | 360k | 30.64 |
| 2020-06-30 | $5.4M | 329k | 16.30 |
| 2020-03-31 | $2.5M | 253k | 9.95 |
| 2019-12-31 | $3.4M | 251k | 13.75 |
| 2019-09-30 | $3.7M | 244k | 15.17 |
| 2019-06-30 | $4.5M | 230k | 19.69 |
| 2019-03-31 | $3.7M | 224k | 16.59 |
| 2018-12-31 | $2.3M | 163k | 14.04 |
| 2018-09-30 | $2.9M | 165k | 17.50 |
| 2018-06-30 | $1.0M | 57k | 18.20 |
| 2018-03-31 | $848k | 45k | 18.77 |
| 2017-12-31 | $627k | 41k | 15.30 |
| 2017-09-30 | $587k | 39k | 14.97 |
| 2017-06-30 | $226k | 24k | 9.30 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management